Parsortix® PC1 Clinical System
The first FDA cleared medical device for the capture and harvest of circulating tumor cells (CTCs) from metastatic breast cancer patient blood for subsequent analysis.
![Parsortix® PC1 Clinical System](/images/products/35/thumbs/56gdyw83yvbinq7jpyx5.png)
The first FDA cleared medical device for the capture and harvest of circulating tumor cells (CTCs) from metastatic breast cancer patient blood for subsequent analysis.